Skip to content

Effect of ayurvedic medicated tablet in prostate enlargement

A Randomised controlled clinical study to evaluate the efficacy of Hingvadi Vati in Vatashthila with special reference to Benign Prostate Hyperplasia. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075892
Enrollment
80
Registered
2024-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Sponsors

Dr Kartikeyan Pramod Pawar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with clinical features of BPH like Reduced urinary flow Hesitancy Urgency of micturition Nocturia Increased frequency of micturition Patients having post voiding residual volume from 50ml to 200ml Patients having International Prostate Symptom Score IPSS mild to moderate score IPSS MORE THAN 19

Exclusion criteria

Exclusion criteria: Diagnosed case of malignancy of Prostate Diagnosed case of urethral stricture Active Urinary tract infection Patients with uncontrolled Diabetes Mellitus TB Malignancy HBV Patients with impaired renal function Other systemic disorders, which can interfere with the course of treatment

Design outcomes

Primary

MeasureTime frame
Reduction in postvoid urine and free urine flowTimepoint: 30days

Secondary

MeasureTime frame
better urine stream & relief to the patientTimepoint: 15 days & 30 days

Countries

India

Contacts

Public ContactDr Vinay Sonambekar

Ayurved Seva Sangha Ayurved Mahavidyalaya,Nashik

sonambekar.chinmay@gmail.com9822624890

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026